CARRIE POWELL: Open Payments
NPI 1093812265 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 7 companies in 2025. Trend: 2023 $499 · 2024 $624 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Amgen Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
Products named: QULIPTA, REXULTI, CAPLYTA, OTEZLA, VAXELIS, AIRSUPRA, VRAYLAR, MOUNJARO.
Industry payments across MT — which companies pay providers there.
